JP5226912B2 - Ｐｐａｒ活性化剤 - Google Patents

Ｐｐａｒ活性化剤 Download PDF

Info

Publication number
JP5226912B2
JP5226912B2 JP2000174803A JP2000174803A JP5226912B2 JP 5226912 B2 JP5226912 B2 JP 5226912B2 JP 2000174803 A JP2000174803 A JP 2000174803A JP 2000174803 A JP2000174803 A JP 2000174803A JP 5226912 B2 JP5226912 B2 JP 5226912B2
Authority
JP
Japan
Prior art keywords
ppar
monoacylglycerol
fatty acid
acid
activator
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2000174803A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001354558A5 (enExample
JP2001354558A (ja
Inventor
孝利 村瀬
正 長谷
一郎 時光
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kao Corp
Original Assignee
Kao Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kao Corp filed Critical Kao Corp
Priority to JP2000174803A priority Critical patent/JP5226912B2/ja
Publication of JP2001354558A publication Critical patent/JP2001354558A/ja
Publication of JP2001354558A5 publication Critical patent/JP2001354558A5/ja
Application granted granted Critical
Publication of JP5226912B2 publication Critical patent/JP5226912B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
JP2000174803A 2000-06-12 2000-06-12 Ｐｐａｒ活性化剤 Expired - Fee Related JP5226912B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2000174803A JP5226912B2 (ja) 2000-06-12 2000-06-12 Ｐｐａｒ活性化剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000174803A JP5226912B2 (ja) 2000-06-12 2000-06-12 Ｐｐａｒ活性化剤

Publications (3)

Publication Number Publication Date
JP2001354558A JP2001354558A (ja) 2001-12-25
JP2001354558A5 JP2001354558A5 (enExample) 2008-02-28
JP5226912B2 true JP5226912B2 (ja) 2013-07-03

Family

ID=18676772

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000174803A Expired - Fee Related JP5226912B2 (ja) 2000-06-12 2000-06-12 Ｐｐａｒ活性化剤

Country Status (1)

Country Link
JP (1) JP5226912B2 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002102364A1 (fr) * 2001-06-18 2002-12-27 Yamada, Sachiko Preparations medicamenteuses agonistes ppar$g(g)
AU2003211997B2 (en) 2002-02-14 2009-01-29 Kirin Beer Kabushiki Kaisha Compositions and foods for improving lipid metabolism
FR2850869B1 (fr) * 2003-02-12 2005-03-25 Genfit S A Utilisations d'aminopropanediols acyles et de leurs analogues azotes et sulfures
DE10314078A1 (de) 2003-03-28 2004-10-14 Nutrinova Nutrition Specialties & Food Ingredients Gmbh Verfahren zur Aufreinigung von Verbindungen mit funktionellen Gruppen
JP4634065B2 (ja) * 2004-05-14 2011-02-16 花王株式会社 アディポネクチン低下抑制剤
JP4972336B2 (ja) * 2006-04-24 2012-07-11 花王株式会社 Ｇｉｐ分泌抑制剤
JP4878494B2 (ja) * 2006-04-24 2012-02-15 花王株式会社 食後血中インスリン上昇抑制剤
JP5798281B2 (ja) * 2006-09-27 2015-10-21 株式会社セラバリューズ ＰＰＡＲγ活性化剤
WO2008084864A1 (ja) * 2007-01-11 2008-07-17 Nisshin Pharma Inc. カプサイシン受容体活性化剤及びそれを噴霧する装置
JP5385572B2 (ja) * 2007-09-28 2014-01-08 出光興産株式会社 Ｐｐａｒ結合作用剤
WO2010149170A1 (en) * 2009-06-24 2010-12-29 Københavns Universitet Treatment of insulin resistance and obesity by stimulating glp-1 release
JP2010241832A (ja) * 2010-07-20 2010-10-28 Kao Corp アディポネクチン低下抑制剤
JP2012171911A (ja) 2011-02-22 2012-09-10 Kao Corp Ｐｐａｒ活性化剤
JP2012171924A (ja) * 2011-02-22 2012-09-10 Kao Corp Ｐｐａｒ活性化剤

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL64542A0 (en) 1981-12-15 1982-03-31 Yissum Res Dev Co Long-chain alpha,omega-dicarboxylic acids and derivatives thereof and pharmaceutical compositions containing them
JP3098560B2 (ja) * 1991-03-28 2000-10-16 花王株式会社 体重増加抑制剤
JP3098561B2 (ja) * 1991-03-28 2000-10-16 花王株式会社 血清トリグリセリド濃度低下剤
JP2969234B2 (ja) * 1991-07-19 1999-11-02 株式会社アドバンス Ａｃａｔ阻害剤
JPH05310567A (ja) * 1992-05-07 1993-11-22 Kao Corp 血清トリグリセリド濃度低下剤
AU718500B2 (en) 1997-01-23 2000-04-13 Sumitomo Pharmaceuticals Company, Limited Remedies for diabetes
JP3607062B2 (ja) * 1997-10-24 2005-01-05 株式会社コーセー 脂肪蓄積抑制剤及びそれを含有する皮膚外用剤
ATE310511T1 (de) * 1997-12-12 2005-12-15 Purdue Research Foundation Verwendung von konjugierten linoleinsäure zur behandlung von type ii diabetes
JP2000355538A (ja) * 1999-04-15 2000-12-26 Kanegafuchi Chem Ind Co Ltd ペルオキシゾーム活性化剤応答性受容体アゴニスト
JP4139544B2 (ja) * 2000-03-06 2008-08-27 花王株式会社 血糖値低下剤
JP2001247473A (ja) * 2000-03-06 2001-09-11 Kao Corp インスリン抵抗性改善剤

Also Published As

Publication number Publication date
JP2001354558A (ja) 2001-12-25

Similar Documents

Publication Publication Date Title
Khan et al. Reviews: current topicsrole of nuclear receptors in the regulation of gene expression by dietary fatty acids
Chapkin et al. Dietary docosahexaenoic and eicosapentaenoic acid: emerging mediators of inflammation
Ulven et al. Dietary fatty acids and their potential for controlling metabolic diseases through activation of FFA4/GPR120
Schmitz et al. The opposing effects of n− 3 and n− 6 fatty acids
JP5226912B2 (ja) Ｐｐａｒ活性化剤
Teitelbaum et al. the role of omega 3 fatty acids in intestinal inflammation
Uauy et al. Essential fatty acids in early life: structural and functional role
Calder et al. Understanding omega-3 polyunsaturated fatty acids
Das Essential fatty acids: biochemistry, physiology and pathology
Cascio et al. Dietary fatty acids in metabolic syndrome, diabetes and cardiovascular diseases
Horrocks et al. Docosahexaenoic acid in the diet: its importance in maintenance and restoration of neural membrane function
Dawczynski et al. Randomized placebo-controlled intervention with n-3 LC-PUFA-supplemented yoghurt: effects on circulating eicosanoids and cardiovascular risk factors
Serini et al. Dietary n-3 polyunsaturated fatty acids and the paradox of their health benefits and potential harmful effects
JP5511126B2 (ja) 脂質改善剤及び脂質改善剤を含んでなる組成物
Petersen et al. Arachidonic acid-dependent inhibition of adipocyte differentiation requires PKA activity and is associated with sustained expression of cyclooxygenases
Nakamura et al. Regulation of hepatic Δ-6 desaturase expression and its role in the polyunsaturated fatty acid inhibition of fatty acid synthase gene expression in mice
Tsuzuki et al. Conjugated docosahexaenoic acid inhibits lipid accumulation in rats
Drenjančević et al. The effect of dietary intake of Omega-3 polyunsaturated fatty acids on cardiovascular health: revealing potentials of functional food
He et al. Delayed induction of Δ-6 and Δ-5 desaturases by a peroxisome proliferator
US20190000795A1 (en) Methods of using cannabinoids and/or molecular similars for modulating, waking-up and/or disabling cellular functions involved in causing disease -- reinvigorating metabolism with anandamide, 2-arachidonoylglycerol and similarly acting compounds
JP2009051732A (ja) Ｐｐａｒリガンド活性を有する組成物
Tsuzuki et al. Intake of conjugated eicosapentaenoic acid suppresses lipid accumulation in liver and epididymal adipose tissue in rats
US20040132819A1 (en) Appetite control method
Ramakers et al. An arachidonic acid-enriched diet does not result in more colonic inflammation as compared with fish oil-or oleic acid-enriched diets in mice with experimental colitis
Bassaganya-Riera et al. Nutrition impact of conjugated linoleic acid: A model functional food ingredient

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060803

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20060803

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080110

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100126

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100329

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20100511

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130212

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20130315

R151 Written notification of patent or utility model registration

Ref document number: 5226912

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R151

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20160322

Year of fee payment: 3

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees